Gerresheimer AG
General ticker "GRRMF" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $1.9B (TTM average)
Gerresheimer AG does not follow the US Stock Market performance with the rate: -38.9%.
Estimated limits based on current volatility of 0.0%: low 51.41$, high 51.41$
Factors to consider:
- Company pays dividends (annually): last record date 2025-06-09, amount 0.05$ (Y0.10%)
Short-term GRRMF quotes
Long-term GRRMF plot
Financial data
| YTD | 2022-11-30 | 2023-11-30 | 2024-11-30 |
|---|---|---|---|
| Operating Revenue | €1,817.09MM | €1,990.49MM | €2,035.90MM |
| Operating Expenses | €1,647.78MM | €1,777.10MM | €1,838.43MM |
| Operating Income | €169.31MM | €213.39MM | €197.47MM |
| Non-Operating Income | €-28.50MM | €-45.96MM | €-50.66MM |
| Interest Expense | €29.08MM | €50.44MM | €60.62MM |
| R&D Expense | €21.62MM | €18.96MM | €22.38MM |
| Income(Loss) | €140.81MM | €167.43MM | €146.81MM |
| Taxes | €38.62MM | €47.34MM | €34.50MM |
| Profit(Loss)* | €96.12MM | €116.13MM | €109.72MM |
| Stockholders Equity | €1,242.92MM | €1,445.66MM | €1,511.56MM |
| Assets | €3,354.29MM | €3,429.14MM | €3,809.16MM |
| Operating Cash Flow | €221.94MM | €294.34MM | €240.33MM |
| Capital expenditure | €238.07MM | €328.04MM | €369.85MM |
| Investing Cash Flow | €-256.18MM | €-307.43MM | €-345.59MM |
| Financing Cash Flow | €44.24MM | €40.35MM | €168.27MM |
| Earnings Per Share** | €3.06 | €3.48 | €3.18 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.